![](/img/cover-not-exists.png)
LBA-01 * Survival outcomes according to body mass index (BMI): results from a pooled analysis of 5 observational or phase IV studies of bevacizumab in metastatic colorectal cancer (mCRC)
Zafar, Y., Hubbard, J., Van Cutsem, E., Hermann, F., Storm, A. J., Gomez, E., Revil, C., Grothey, A.Volume:
26
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdv262.01
Date:
June, 2015
File:
PDF, 31 KB
english, 2015